JP2018506554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018506554A5 JP2018506554A5 JP2017544867A JP2017544867A JP2018506554A5 JP 2018506554 A5 JP2018506554 A5 JP 2018506554A5 JP 2017544867 A JP2017544867 A JP 2017544867A JP 2017544867 A JP2017544867 A JP 2017544867A JP 2018506554 A5 JP2018506554 A5 JP 2018506554A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- less
- water
- particles
- nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000203 mixture Substances 0.000 claims 14
- 239000002245 particle Substances 0.000 claims 9
- 239000002105 nanoparticle Substances 0.000 claims 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims 2
- 229940086555 cyclomethicone Drugs 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000003961 penetration enhancing agent Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000080 wetting agent Substances 0.000 claims 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 1
- WTJXVDPDEQKTCV-UHFFFAOYSA-N 4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydron;chloride Chemical group Cl.C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2C1CC1C(N(C)C)C(=O)C(C(N)=O)=C(O)C1(O)C2=O WTJXVDPDEQKTCV-UHFFFAOYSA-N 0.000 claims 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 206010021531 Impetigo Diseases 0.000 claims 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 229940008099 dimethicone Drugs 0.000 claims 1
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 1
- 239000003349 gelling agent Substances 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 229960004023 minocycline Drugs 0.000 claims 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical group C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 claims 1
- 229960002421 minocycline hydrochloride Drugs 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN623MU2015 | 2015-02-25 | ||
| IN623/MUM/2015 | 2015-02-25 | ||
| PCT/IN2016/050068 WO2016135754A1 (en) | 2015-02-25 | 2016-02-25 | Nanoparticulate composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018506554A JP2018506554A (ja) | 2018-03-08 |
| JP2018506554A5 true JP2018506554A5 (enExample) | 2019-05-16 |
Family
ID=56789380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017544867A Ceased JP2018506554A (ja) | 2015-02-25 | 2016-02-25 | ナノ粒子組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10512608B2 (enExample) |
| EP (1) | EP3261619A4 (enExample) |
| JP (1) | JP2018506554A (enExample) |
| AU (1) | AU2016224863A1 (enExample) |
| CA (1) | CA2977612A1 (enExample) |
| WO (1) | WO2016135754A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| EP2482788B1 (en) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| US20220152033A1 (en) * | 2020-11-17 | 2022-05-19 | Arcutis Biotherapeutics, Inc. | Compositions and methods for deep dermal drug delivery |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122519A (en) | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
| US20040115134A1 (en) * | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
| CA2436574A1 (en) * | 2000-12-06 | 2002-06-13 | Pharmacia Corporation | Laboratory scale milling process |
| US20080220075A1 (en) | 2002-03-20 | 2008-09-11 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| EP1551457A1 (en) * | 2002-07-16 | 2005-07-13 | Elan Pharma International Limited | Liquid dosage compositions of stable nanoparticulate active agents |
| US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US20160158261A1 (en) | 2002-10-25 | 2016-06-09 | Foamix Pharmaceuticals Ltd. | Antibiotic Kit and Composition and Uses Thereof |
| GB0403702D0 (en) | 2004-02-19 | 2004-03-24 | Boots Co Plc | Skincare compositions |
| US8920821B2 (en) * | 2006-04-14 | 2014-12-30 | Perrigo Israel Pharmaceuticals Ltd. | Pharmaceutical compositions comprising silica microspheres |
| WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| WO2008097851A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tetracycline compositions for topical administration |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| JP2011526302A (ja) | 2008-06-26 | 2011-10-06 | アンテリオス， インコーポレイテッド | 経皮送達 |
| US8784852B2 (en) | 2009-02-27 | 2014-07-22 | Audrey Kunin | Topical skin care composition |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| EP2482788B1 (en) | 2009-10-02 | 2022-12-14 | Journey Medical Corporation | Topical tetracycline compositions |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US20140086975A1 (en) | 2010-10-15 | 2014-03-27 | Rutgers, The State University Of New Jersey | Hydrogel formulation for dermal and ocular delivery |
| CN108619519A (zh) | 2011-01-19 | 2018-10-09 | 护肤品实验室有限公司 | 局部米诺环素组合物及其使用方法 |
| PT106679B (pt) | 2012-11-27 | 2015-03-25 | Hovione Farmaciencia Sa | Formulações tópicas de tetraciclinas, sua preparação e usos |
| US20160287614A1 (en) | 2013-11-20 | 2016-10-06 | Lupin Limited | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic |
| WO2015114666A2 (en) | 2014-01-29 | 2015-08-06 | Vyome Biosciences Pvt. Ltd. | Treatments for resistant acne |
-
2016
- 2016-02-25 JP JP2017544867A patent/JP2018506554A/ja not_active Ceased
- 2016-02-25 US US15/552,966 patent/US10512608B2/en not_active Expired - Fee Related
- 2016-02-25 WO PCT/IN2016/050068 patent/WO2016135754A1/en not_active Ceased
- 2016-02-25 AU AU2016224863A patent/AU2016224863A1/en not_active Abandoned
- 2016-02-25 CA CA2977612A patent/CA2977612A1/en not_active Abandoned
- 2016-02-25 EP EP16754875.9A patent/EP3261619A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018506554A5 (enExample) | ||
| KR100990810B1 (ko) | 안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도 | |
| ES2303645T3 (es) | Composiciones para prevenir y tratar sintomas de tipo resfriado y gripe que comprenden cinc quelado. | |
| Molaei | Magnetic graphene, synthesis, and applications: A review | |
| JP2013513612A5 (enExample) | ||
| DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
| CA3068675C (en) | A nano-sulfur containing composition and application thereof | |
| JP2009280627A5 (enExample) | ||
| JP5740393B2 (ja) | 皮膚および爪の真菌感染症の局所治療に適した組成物 | |
| CN106132401A (zh) | 用于增强酸性有益剂的局部施用的组合物及方法 | |
| CN101808637A (zh) | 医药组合物 | |
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| WO2008097530A1 (en) | Increased effectiveness of allylamine drug compounds | |
| Ranneh et al. | The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles | |
| Xu et al. | Antifungal nanomaterials: Current progress and future directions | |
| JP2017511347A (ja) | 頭皮ケア組成物 | |
| Mahdavian | DFT studies of the drug carrier of anti-migraine (sumatriptan) on nano-graphene oxide (NGO) and graphene oxide/polyethylene glycol polymer nano-composite | |
| CN1735434A (zh) | 用于预防和治疗伤风与类流感症状的包含精选粘附聚合物的组合物 | |
| TW201236697A (en) | Oral and personal care compositions | |
| ES2861052T3 (es) | Composición tópica que comprende oxibutinina para el tratamiento de la hiperhidrosis | |
| US20220142914A1 (en) | Suspension formulations of high load dispersions | |
| JP2014534215A5 (enExample) | ||
| JP2007091686A (ja) | ヒノキチオールを含有するナノ粒子 | |
| Sekar et al. | Characterization and Formulation of Miswak Film for the Treatment of Chronic Periodontitis: An: In Vitro: Study | |
| CN110139641A (zh) | 外用组合物 |